-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FLhF79p1WY0qUWEZflp1/6GoaoIwE6JTyWoWIgkcXKb0gK4AzFGg91AAgHLFditD k5vBuBlsMBU+/3fipj2njg== 0001181431-08-004742.txt : 20080122 0001181431-08-004742.hdr.sgml : 20080121 20080122173347 ACCESSION NUMBER: 0001181431-08-004742 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080117 FILED AS OF DATE: 20080122 DATE AS OF CHANGE: 20080122 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HOLLIS EDEN PHARMACEUTICALS INC /DE/ CENTRAL INDEX KEY: 0000899394 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133697002 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-587-9333 MAIL ADDRESS: STREET 1: 4435 EASTGATE MALL STREET 2: SUITE 400 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INITIAL ACQUISITION CORP DATE OF NAME CHANGE: 19930329 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRINCKE JAMES M CENTRAL INDEX KEY: 0001239656 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24672 FILM NUMBER: 08542833 MAIL ADDRESS: STREET 1: C/O HOLLIS-EDEN PHARMACEUTICALS STREET 2: 4435 EASTGATE MALL STE.400 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 rrd190883.xml FORM 4 STOCK OPTIONS JANUARY 2008 X0202 4 2008-01-17 0 0000899394 HOLLIS EDEN PHARMACEUTICALS INC /DE/ HEPH 0001239656 FRINCKE JAMES M 4435 EASTGATE MALL SUITE 400 SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Stock Option (Right to Buy) 1.62 2008-01-17 4 A 0 60000 0 A 2018-01-16 Common Stock 60000 60000 D Stock Option (Right to Buy) 1.62 2008-01-17 4 A 0 3000 0 A 2018-01-16 Common Stock 3000 3000 D Stock Option (Right to Buy) 1.62 2008-01-17 4 A 0 60000 0 A 2018-01-16 Common Stock 60000 60000 D 25% of the shares subject to the Stock Option shall vest and become exercisable on the first anniversary of the date of grant. The balance of the shares shall vest and become exercisable in 36 equal monthly installments thereafter. Fully vested and exercisable upon grant. The shares subject to the Stock Option shall vest and become exercisable in 12 equal monthly installments. Robert W. Weber, Attorney-in-Fact 2008-01-22 -----END PRIVACY-ENHANCED MESSAGE-----